 |
Alpha1-proteinase inhibitor (human) |
|---|---|
| Trade Name | |
| Orphan Indication | For slowing the progression of emphysema in alpha1-antitrypsin deficient patients |
| USA Market Approval | USA |
| USA Designation Date | 1999-11-24 00:00:00 |
| Sponsor | CSL Behring L.L.C.;1020 First Ave., PO Box 61501;King of Prussia, Pennsylvania, 19406 |
